The ecRNAs, they say, are fundamental regulators of DNA
methylation patterns
in the adult brain
through interaction with DNA methyltransferase enzymes, and the ecRNAs may offer a promising future therapeutic avenue to treat neuropsychiatric disease states associated with
changes in DNA
methylation, as they report
in the July 7 issue of Nature Communications.